The novel treatment is in development to address critical cardiac patients with a life-threatening condition and represents a significant milestone for the academic medical system's minimally invasive valve program.

TAMPA, Fla., May 9, 2025 /PRNewswire/ -- Interventional structural cardiologists at Tampa General Hospital (TGH) and USF Health have completed the first procedure in Florida under the FDA Early Feasibility Study pathway for the TricValve® System. The procedure took place in April 2025 on a patient with severe Tricuspid Regurgitation (TR), a life-threatening cardiac condition.

Recommended for you